In Vivo Myocardial Microcirculatory Function
体内心肌微循环功能
基本信息
- 批准号:7894700
- 负责人:
- 金额:$ 33.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-12-01 至 2011-09-30
- 项目状态:已结题
- 来源:
- 关键词:12 year oldAddressAdultAffectAgeAnatomyAnimalsApplications GrantsAreaArteriesAtherosclerosisAutomobile DrivingBlood VolumeBlood capillariesCalciumCaliberCardiomyopathiesCharacteristicsCholesterolChronicClinicalClinical ResearchClinical TrialsClinical assessmentsContrast MediaCoronaryCoronary ArteriosclerosisCoronary StenosisCoronary arteryDefectDevelopmentDietDiseaseDisease modelElectrocardiogramElectron BeamFailureFamily history ofFamily suidaeFeasibility StudiesFemaleFunctional disorderFutureGoalsHeart RateHumanHyperlipidemiaImageImage AnalysisImpairmentIndividualInjection of therapeutic agentInterventionIntravenous BolusIschemiaLaboratoriesLipidsMedicalMethodologyMethodsMicrocirculationMicroscopicMicrospheresModelingMonitorMyocardialMyocardial perfusionMyocardiumNoiseOnset of illnessPatientsPerfusionPermeabilityPlasmaPlasticsPremenopauseProcessReproducibilityResearchResearch DesignResearch Project GrantsResolutionRiskRisk FactorsScanningSensitivity and SpecificitySeveritiesSignal TransductionSimulateSliceSourceSpasmStagingSurfaceSymptomsTechniquesTherapeutic EmbolizationThickTranslatingVasomotorWomanX-Ray Computed Tomographyarteriolebasecalcificationcapillarydriving forceexperiencefeedinghypercholesterolemiain vivoindexingmalemenminimally invasivenew technologyolder patientvolunteer
项目摘要
Our proposal translates a minimally invasive CT-based approach, developed in pigs, to the clinical research arena.
The overall goal of this proposal is to address the clinical problem of detecting impairment of myocardial microcirculatory function, such as occurs in atherosclerosis, prior to symptoms due to narrowing of epicardial coronary arteries or due to myocardial failure in some cardiomyopathies.
The hypothesis driving our proposed approach is that the myocardial microcirculation is affected early in these disease processes and can be detected by virtue of development of microvascular disturbances of vasomotor tone, increased endothelial permeability and/or development of scattered microscopic myocardial perfusion defects.
Our approach is to quantitate such microvascular changes by the use of a fast-CT-based methodology (developed in our laboratory using pig models of these disease processes) to demonstrate that we can detect and quantitate those microvascular changes in patients who have increased risk factors for atherosclerosis, or have impaired LV function, but without clinical evidence of epicardial coronary artery disease.
This current grant proposal is basically a feasibility trial to establish whether our CT-based methodology has the sensitivity needed to be of use in future clinical trials. This new methodology is based on our previous findings and to apply this methodology to these groups of subjects:
Image analysis developments using Electron Beam CT (but recently using multislice, dual-source CT) scans of a pig model of various aspects of microvascular disturbance within the myocardium, have shown that:
(a) myocardial perfusion (F) and intramyocardial blood volume (Bv) can be quantitated using an intravenous bolus injection of contrast medium;
(b) the myocardial blood volume-to-flow relationship characterizes the conduit (i.e., arterioles) and exchange (i.e., capillaries) components of the myocardial microcirculation;
(c) the delayed washout components of the myocardial contrast dilution curve provide an index of microcirculatory endothelial permeability (PS product);
(d) the size and number of micro-perfusion defects (i.e., arteriolar perfusion territories reflecting the arteriolar dysfunction) can be quantitated and
(e) the severity of LV dysfunction is proportional to the cumulative surface area of those perfusion defects more so than to the cumulative volume of non-perfused myocardium.
Our Specific Aims are therefore:
AIM I Normal subjects (24).
AIM II Patients with elevated risk for atherosclerosis due to hyperlipidemia without coronary calcium (24).
AIM III Patients with idiopathic cardiomyopathy but no epicardial coronary artery stenosis or calcification (24).
Subjects in each group would be 40-55 years old, twelve pre-menopausal women and twelve age-range-matched men. All selected subjects will have a coronary calcium scan (if not already obtained clinically) as well as a myocardial perfusion scan.
The Significance of this approach is that if the CT-based method can identify the early microvascular onset of the disease processes, medical intervention is more likely to arrest or even reverse the disease process before irreversible damage occurs.
我们的建议将在猪身上开发的基于CT的微创方法转化为临床研究竞技场。
该提案的总体目标是解决在心外膜冠状动脉狭窄或某些心肌病中的心肌衰竭引起的症状之前检测心肌微循环功能受损的临床问题,例如动脉粥样硬化中发生的心肌微循环功能受损。
驱动我们提出的方法的假设是,心肌微循环在这些疾病过程的早期受到影响,并且可以通过血管紧张素的微血管紊乱、内皮通透性增加和/或分散的微观心肌灌注缺陷的发展来检测。
我们的方法是通过使用基于快速CT的方法(在我们的实验室中使用这些疾病过程的猪模型开发)来定量这种微血管变化,以证明我们可以检测和定量动脉粥样硬化风险因素增加或LV功能受损但没有心外膜冠状动脉疾病临床证据的患者的微血管变化。
目前的拨款建议基本上是一个可行性试验,以确定我们的CT为基础的方法是否具有在未来的临床试验中使用所需的灵敏度。这种新方法是基于我们以前的研究结果,并将这种方法应用于这些受试者群体:
使用心肌内微血管紊乱的各个方面的猪模型的电子束CT(但最近使用多层、双源CT)扫描的图像分析发展已经表明:
(a)心肌灌注(F)和心肌内血容量(Bv)可以使用造影剂的静脉内团注来定量;
(b)心肌血容量-流量关系表征导管(即,小动脉)和交换(即,毛细血管)心肌微循环的组成部分;
(c)心肌造影剂稀释曲线的延迟洗脱成分提供了微循环内皮渗透性指数(PS产品);
(d)微灌注缺陷的大小和数量(即,反映小动脉功能障碍的小动脉灌注区域)可以被定量,
(e)LV功能障碍的严重程度与这些灌注缺陷的累积表面积成比例,比与未灌注心肌的累积体积成比例更大。
因此,我们的具体目标是:
AIM I正常受试者(24)。
无冠状动脉钙化的高脂血症导致动脉粥样硬化风险升高的患者(24)。
无心外膜冠状动脉狭窄或钙化的特发性心肌病患者(24)。
每组中的受试者将为40-55岁,12名绝经前女性和12名年龄范围匹配的男性。所有选定的受试者将接受冠状动脉钙扫描(如果尚未在临床上获得)以及心肌灌注扫描。
这种方法的意义在于,如果基于CT的方法可以识别疾病过程的早期微血管发作,则医疗干预更有可能在不可逆损伤发生之前阻止甚至逆转疾病过程。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT.
- DOI:10.1007/s10554-015-0619-9
- 发表时间:2015-04
- 期刊:
- 影响因子:0
- 作者:Miller WL;Behrenbeck TR;McCollough CH;Williamson EE;Leng S;Kline TL;Ritman EL
- 通讯作者:Ritman EL
Examine thy heart with all diligence: evaluation of cardiac function using fast computed tomography.
尽全力检查您的心脏:使用快速计算机断层扫描评估心脏功能。
- DOI:10.1161/01.hyp.0000253086.74365.52
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Daghini,Elena;Ritman,ErikL;Lerman,LilachO
- 通讯作者:Lerman,LilachO
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erik Leo Ritman其他文献
Erik Leo Ritman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erik Leo Ritman', 18)}}的其他基金
CT Method Development for Quantifying Myocardial Microvascular Flow Distribution
量化心肌微血管血流分布的 CT 方法开发
- 批准号:
8604416 - 财政年份:2013
- 资助金额:
$ 33.6万 - 项目类别:
CT Method Development for Quantifying Myocardial Microvascular Flow Distribution
量化心肌微血管血流分布的 CT 方法开发
- 批准号:
8425620 - 财政年份:2013
- 资助金额:
$ 33.6万 - 项目类别:
Coronary Vasa Vasorum - Role of 3D Branching Geometry
冠状动脉 Vasa Vasorum - 3D 分支几何的作用
- 批准号:
6537854 - 财政年份:2001
- 资助金额:
$ 33.6万 - 项目类别:
Coronary Vasa Vasorum - Role of 3D Branching Geometry
冠状动脉 Vasa Vasorum - 3D 分支几何的作用
- 批准号:
7568777 - 财政年份:2001
- 资助金额:
$ 33.6万 - 项目类别:
Coronary Vasa Vasorum - Role of 3D Branching Geometry
冠状动脉 Vasa Vasorum - 3D 分支几何的作用
- 批准号:
6638676 - 财政年份:2001
- 资助金额:
$ 33.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Research Grant